Clinical trial

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

NCT03554174

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2018-02-27

PhasePHASE1

Study timeline

Study start (actual)2018-02-27Date precision: day

Registry last updated2025-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Low Dose PsilocybinDRUG

PlaceboDRUG

Medium Dose PsilocybinDRUG

Sponsors & collaborators

Yale Universitylead sponsor

Heffter Research Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03554174 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.